张学松, 张谢, 黄诗良, et al. Detection ofGATA5gene methylation in plasma and stool of colorectal cancer and the clinical diagnosis[J]. China Oncology, 2014, 24(7): 501-506.
张学松, 张谢, 黄诗良, et al. Detection ofGATA5gene methylation in plasma and stool of colorectal cancer and the clinical diagnosis[J]. China Oncology, 2014, 24(7): 501-506. DOI: 10.3969/j.issn.1007-3969.2014.07.004.
Detection ofGATA5gene methylation in plasma and stool of colorectal cancer and the clinical diagnosis
背景与目的:结直肠癌(colorectal cancer,CRC)是全球发病率第三,死亡率第四的恶性肿瘤。遗传学及表观遗传学的改变引发抑癌基因甲基化表达沉默是CRC发生的重要原因,本研究旨在探讨血浆、粪便GATA5启动子甲基化检测在CRC临床诊断中的应用价值。方法:收集34例健康体检者和43例CRC患者的血浆和配对的粪便标本。采用甲基化特异性PCR法(methylation specific PCR method,MSP)检测其血浆、粪便中GATA5甲基化水平,并分析其与临床病理特征相关性。结果:MSP结果显示CRC患者血浆、粪便中GATA5启动子甲基化率(60.74%、76.60%)高于健康者发生率(26.47%、32.35%),差异均有统计学意义(P值分别为0.006 7,0.000 2)。CRC患者血浆甲基化发生率与临床分期(P=0.000 5)、淋巴结转移(P=0.020)密切相关,而粪便GATA5甲基化水平与临床病理特征无统计学意义。结论:检测粪便GATA5甲基化水平并辅以血浆GATA5甲基化水平可作为一种简单、非侵入、敏感及特异的方法应用于CRC患者的临床诊断。
Abstract
Background and purpose: Colorectal cancer (CRC) is a malignancy which is the third incidence and the fourth mortality in the worldwide. The main reason for the development of CRC is that the changes of genetic and epigenetic causes the tumor suppressor gene methylation silencing. This study aimed to investigate the plasma and stool GATA5 gene promoter methylation was detected in clinical diagnosis of CRC. Methods: To collect the paired plasma and stool specimens of 34 cases of healthy and 43 cases of patients with CRC. Methylation specific PCR (MSP) was respectively detected the GATA5 gene methylation levels of GATA5 gene in plasma and stool. And then separately analyzed their correlations with clinical and pathological parameters in gastric carcinoma. Results: The result of MSP showed that GATA5 gene promoter methylation rates in plasma and stool of CRC patients were 60.74%
76.60%
respectively
were higher than those of healthy persons (6.47%
32.35%). And the differences were statistically significant (P=0.006 7
P=0.000 2
respectively). GATA5 gene methylation rates in plasma of CRC patients were closely related to clinical stage (P=0.000 5) and lymph node metastasis(P=0.020)
while GATA5 gene methylation rates in stool of CRC patients had no significant with clinical and pathological parameters. Conclusion: Detection of faecal GATA5 gene methylation level and supplemented plasma GATA5 gene methylation level can become a simple
non-invasive
sensitive and specific method for clinical diagnosis of CRC.
Detection of HIC1 promoter methylation in prostate cancer using MSP and BSP methods
The relationship between methylation of ERCC1 gene in peripheral blood and in gastric cancer tissues
Targeted therapy and immunotherapy combined with chemotherapy bring effective response to AFP positive colon cancer patients: a case report and literature review
Mechanisms underlying tepoxalin-mediated regulation of cell growth and chemoresistance via ABCB1 in colorectal cancer
Research progress and prospects of exercise intervention in comprehensive management of colorectal cancer
Related Author
单孟林
丁 滔
郑江花
王红兵
陈卫昌
LIU Miao
LI Jinze
WU Chensi
Related Institution
复旦大学附属公共卫生临床中心医学检验科
上海交通大学附属第六人民医院南院泌尿外科
苏州大学附属第一医院消化内科
徐州医学院附属医院肿瘤内科
Department of Gastroenterology, the Fourth Hospital of Hebei Medical University